Reuters logo
BRIEF-Ab Science announces positive Masitinib phase 2 results
February 2, 2015 / 5:32 PM / 3 years ago

BRIEF-Ab Science announces positive Masitinib phase 2 results

Feb 2 (Reuters) - Ab Science SA :

* Announces positive phase 2 clinical study data of Masitinib in second-line metastatic stomach cancer

* Announces positive results from phase 2 study with investigational drug Masitinib in patients with nonresectable, metastatic esophagogastric adenocarcinoma Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below